Kimera Labs Advances in Healthy Aging with $101 Million XPRIZE Healthspan Semifinalist Recognition Kimera Labs, a leader in therapeutic exosome biotechnology, proudly announces its semifinalist position in the prestigious $101 million XPRIZE Healthspan competition, aiming to enhance healthy human lifespans.

Kimera Labs Advances in Healthy Aging with $101 Million XPRIZE Healthspan Semifinalist Recognition #USA #Miramar #Kimera_Labs #Exosome_Biotechnology #Healthspan_Competition